AI assistant
Sending…
biote Corp. — Director's Dealing 2022
Nov 18, 2022
33946_dirs_2022-11-18_8087ca4a-f86c-4ee5-8d26-f56685dc7740.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: biote Corp. (BTMD)
CIK: 0001819253
Period of Report: 2022-11-15
Reporting Person: Cone Stephen Mark (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-11-15 | Stock Option (Right to Buy) | $3.97 | A | 31696 | Acquired | 2032-11-14 | Class A Common Stock (31696) | Direct |
Footnotes
F1: All shares subject to the option award shall vest on the earlier of May 26, 2023 or the day prior to the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.
More from biote Corp.
Regulatory Filings
2026
May 18
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Jan 26
Interim / Quarterly Report
2025
Nov 7
Regulatory Filings
2025
Nov 5
Interim / Quarterly Report
2025
Aug 8
Regulatory Filings
2025
Aug 6
Major Shareholding Notification
2025
Jun 12
Director's Dealing
2025
Jun 11
Regulatory Filings
2025
Jun 9